This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Oregon Health & Science University. Active years: 2006-2010.
Company Filing History:
Years Active: 2006-2010
Title: Marcelo Rubinstein: Innovator in Genetic Research
Introduction
Marcelo Rubinstein is a prominent inventor based in Buenos Aires, Argentina. He has made significant contributions to the field of genetic research, particularly in the study of the proopiomelanocortin (POMC) gene. With a total of 2 patents, his work has implications for understanding various biological processes.
Latest Patents
Rubinstein's latest patents focus on the upstream control elements of the proopiomelanocortin gene and their applications. The patents disclose the nucleic acid sequence of the POMC enhancer, including sequences from various species such as human, rat, rabbit, hamster, mouse, and cow. Additionally, the patents describe hybrid transgenes that comprise a POMC transcriptional control element operably linked to a nucleic acid sequence encoding a marker. Furthermore, transgenic mice carrying a hybrid transgene that includes a POMC control element operably linked to a marker are also detailed in his patents.
Career Highlights
Marcelo Rubinstein is affiliated with Oregon Health & Science University, where he conducts his research. His work has garnered attention in the scientific community, contributing to advancements in genetic engineering and molecular biology.
Collaborations
Rubinstein has collaborated with notable colleagues, including Flavio Silva Junqueira De Souza and Malcolm J Low. These partnerships have enhanced the scope and impact of his research endeavors.
Conclusion
Marcelo Rubinstein's innovative work in genetic research, particularly regarding the POMC gene, showcases his dedication to advancing scientific knowledge. His contributions continue to influence the field and inspire future research.